Expand your expertise in managing transthyretin amyloid cardiomyopathy (ATTR-CM) with our program designed for specialty pharmacists. Our expert-led sessions will provide an in-depth review of the latest on this disease landscape, including genetic variations, evolving patient profiles, and the most up-to-date data. You'll explore the growing field of ATTR-CM therapies and gain insights into how specialty pharmacies can ensure patient access to these treatments. Learn how to interpret clinical trial data on emerging therapies, effectively apply your knowledge in real-world situations, and ultimately elevate the standard of care for your ATTR-CM patients.
In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should claim only the credit commensurate with the extent of their participation in the activity. 
Global Learning Collaborative (GLC) designates this activity for 1.5 contact hours/0.15CEUs of pharmacy contact hours.
